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AIMS AND SCOPE 
 
Aims and Scope                                                                        
 
npj Primary Care Respiratory Medicine is an open access, 
online-only, multidisciplinary journal dedicated to publishing 
high-quality research in all areas of the primary care 
management of respiratory and respiratory-related allergic 
diseases. Papers published by the journal represent 
important advances of significance to specialists within the 
fields of primary care and respiratory medicine. We are 
particularly interested in receiving papers in relation to the 
following aspects of respiratory medicine, respiratory-related 
allergic diseases and tobacco control:  
• Epidemiology 
• Prevention 
• Clinical care 
• Service delivery and organisation of healthcare 
(including implementation science) 
• Global health 
The journal is fully-indexed, international academic 
publication relevant to anyone with an interest in the primary 
care management of respiratory and respiratory-related 
allergic diseases. It is the official journal of the Primary Care 
Respiratory Society UK (PCRS-UK) and the International 
Primary Care Respiratory Group (IPCRG). The journal 
publishes Articles, Review Articles, Perspectives, 
Correspondence, Brief Communications, Editorials, 
Protocols and Case Reports. We are interested in research 
undertaken using all appropriate study designs, these 
including observational and analytical studies, qualitative 
research, randomised controlled trials, implementation 
research and systematic reviews. 
 
Mission 
The mission of npj Primary Care Respiratory Medicine is: 
1. To provide an authoritative setting for the 
publication of high-quality internationally-relevant 
clinical research that is essential to the future of 
primary care management of patients with 
respiratory and respiratory-related allergic 
diseases. 
2. To inform and educate healthcare professionals 
worldwide of the research and service 
developments of relevance to primary care that 
promote excellence in the care of patients with 
respiratory and respiratory-related allergic 
diseases. 
Audience 
 
The journal is relevant to a wide international 
multidisciplinary audience, including primary, secondary and 
tertiary care respiratory specialists, respiratory 
physiotherapists, dieticians and nurses. Contributions come 
from clinicians and academics working within any sector that 
affects the primary care management of respiratory and 
respiratory-related allergic diseases in primary and 
community care settings. A non-exhaustive overview of the 
audiences relevant to the journal is below. 
• Ambulatory care 
• Community care 
• Community medicine 
• Epidemiology 
• Family medicine 
• First port of call 
• General paediatrics 
• General practice 
• Global health 
• Health policy 
• Health services research 
• Implementation research 
• Integrated care pathways 
• Internal medicine 
• Office-based internal medicine 
• Medicine 
• Pharmaceutical industry 
• Pharmacy  
• Primary care  
• Public health 
• Respiratory epidemiology 
• Respiratory infections 
• Smoking cessation 
• Social sciences 
Relationship to other Nature journals 
npj Primary Care Respiratory Medicine is the new title for 
Primary Care Respiratory Journal following the 
establishment of a new publishing partnership between 
Springer Nature and Primary Care Respiratory Society UK. 
 
npj Primary Care Respiratory Medicine is editorially 
independent. The editors make their own decisions, 
independently of the other Nature Research journals.  
 
If a paper is rejected from one Nature Research journal, the 
authors can use an automated manuscript transfer service 
2 
 
 
 
to submit the paper to the journal via a link sent to them by 
the editor handling the manuscript.  
 
In cases where manuscripts are rejected from npj Primary 
Care Respiratory Medicine, authors may wish to use the 
same manuscript transfer service to submit their paper to 
other Nature Research journals.  
 
For more information, please consult the following: 
Details of the manuscript transfer service 
Listing of all Nature journals 
 
Journal Details 
Editors-in-Chief:   
Professor Aziz Sheikh  
Professor of Primary Care Research and Development, 
Allergy and Respiratory Research Group, Centre for 
Population Health Sciences, The University of Edinburgh, 
Edinburgh, UK  
 
Dr. Paul Stephenson  
Old Bridge Surgery, Looe, Cornwall, UK; Honorary Clinical 
Research Fellow, Allergy and Respiratory Research Group, 
Centre for Population Health Sciences, The University of 
Edinburgh, Edinburgh, UK   
 
Editorial office:  
Springer Nature, London, UK 
Email: npjpcrm@nature.com 
Tel: +1 212 726 9387 
 
Impact Factor 
Primary Care Respiratory Journal: 2.434* 
npj Primary Care Respiratory Medicine: 1.447** 
  
2015 Journal Citation Report (Thomson Reuters, 2016) 
* Due to the change of title in April 2014, the journal has 
been assigned two impact factors: one relating to the old 
title and one relating to the new title. 
 
** npj Primary Care Respiratory Medicine has only received 
a partial impact factor due to its launch midway through the 
impact factor calculation. 
 
Abstracted in: 
• Thomson Reuters ISI 
• Scopus 
• PubMed/Medline 
• PubMed Central
ARTICLE TYPE SPECIFICATIONS 
 
 
Article Description Abstract  Word Limit Tables/ 
Figures 
References 
Article  
A complete, comprehensive report of original 
research. An Article usually has a fairly complex 
narrative that is based on multiple techniques 
and/or approaches. 
Unstructured abstract; 
max word limit: 250 
5,000 words 
excluding 
abstract, 
references, 
figures and 
tables 
 
Max of 6 Max of 50. 
Please use 
as current 
as possible.  
Review  
A comprehensive synthesis and/or analysis of 
specific topics. A short Introduction giving the 
rationale for the review should be followed by 
sections with appropriate subheadings, followed 
by a conclusions section at the end. The standard 
footer headings (Acknowledgements, 
Contributions, Competing Interests, Funding) are 
required. All invited reviews will undergo peer 
review prior to acceptance. 
 
Unstructured abstract; 
max word limit: 250 
5,000 words 
excluding 
abstract, 
references, 
figures and 
tables 
Max of 8 Max of 100 
Brief Communication 
A concise report of research of high quality and 
broad interest to a journal’s target audience. 
Usually a short report of interim work or final 
report of research that does not warrant a full 
research paper publication. 
 
Unstructured abstract; 
max word limit: 150 
800 words 
excluding 
references 
Max of 2 Max of 10 
Editorial 
An authoritative timely opinion on an issue or a 
paper; it is usually written or invited by the Editors-
in-Chief. 
None 1,000 words 
excluding 
references 
Max of 2 Max of 15 
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Correspondence  
The Editors will occasionally consider the 
publication of correspondence developing the 
debate relating to a particular journal article that 
has already been published. These pieces are not 
applicable for an Article Processing Charge. The 
Correspondence should be received within 6 
weeks after publication of the journal article to 
which it refers. 
 
None 350 words 
max 
excluding, 
references, 
figures and 
tables 
None Max of 5, 
not 
including 
reference to 
the original 
article. 
Perspective 
It should provide an evidence-based opinion on a 
particular article or subject. There should be a 
short introduction, followed by relevant section 
headings and a conclusions’ section at the end. 
The standard footer headings 
(Acknowledgements, Contributions, Competing 
Interests, Funding) are required. 
 
Unstructured abstract; 
max word limit: 250 
2,000 words 
excluding 
abstract, 
references, 
figures and 
tables 
Max of 3 Max of 50 
Case Report 
The Editors welcome submission of patient-
oriented evidence-based case reports. The 
case(s) might highlight guideline-defined 
management and/or substantially advance 
thinking on primary care management. A 
Discussion section should highlight the 
educational nature of the case(s) being presented. 
 
Unstructured abstract; 
max word limit: 250 
2,000 words 
excluding 
abstract, 
references, 
figures and 
tables 
Max of 2 Max of 50 
Case-based Learning Article 
These are educational articles aimed at practising 
clinicians. They are usually commissioned by the 
Education section Editors. Unsolicited 
submissions are welcome but we strongly advise 
you to contact the Education section Editors with 
an outline of your proposed article so that they can 
advise on general suitability and to avoid 
duplication. A clinical scenario (vignette) should 
set the scene for a structured discussion on the 
management of any respiratory or respiratory-
related allergic condition likely to be encountered 
in primary care. The discussion should highlight 
aspects of evidence-based management of 
relevance to primary care, and offer a practical 
interpretation of guideline recommendations. 
There should be a Conclusions section at the end. 
The standard footer headings are required. 
 
Unstructured abstract; 
max word limit: 250 
2,000 words 
excluding 
abstract, 
references, 
figures and 
tables 
Max of 2 Max of 20 
Protocol 
The Editors welcome submission of Protocols of 
systematic reviews/meta-analyses, randomised 
trials and epidemiological studies, submitted prior 
to or shortly after authors embark on their 
research. See the detailed instructions below. 
 
None  1,500 words 
excluding 
references 
Max of 2 Max of 50 
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PREPARATION OF ARTICLES 
 
 
1. ARTICLES 
Papers submitted for consideration in npj Primary Care 
Respiratory Medicine can be in any standard format 
accepted by other journals in the field, as long as all the 
elements cited below are included. 
 
Articles accepted for publication in npj Primary Care 
Respiratory Medicine must contain the following 
components in the order stated, please see below for further 
details. 
 
 Title page 
 Abstract and keywords 
 Introduction 
 Results 
 Discussion  
 Methods 
 Acknowledgements 
 Competing Interests 
 Contributions 
 Funding 
 References 
 Figure legends 
 Tables 
 Figures 
 
Cover Letter: The uploaded cover letter must state the 
material is original, has not been previously published and 
has not been submitted for publication elsewhere while 
under consideration. A Competing Interests statement 
should also be included. 
Manuscript text: All textual content is provided in a single 
file, prepared using either Word or TeX/LaTeX; figures are 
provided in individual files.  
 
Word: Nature Partner Journals do not use a manuscript 
template for Word documents. The manuscript file should 
be formatted as double spaced, single-column text without 
justification. Pages should be numbered using an Arabic 
numeral in the footer of each page. Standard fonts are 
recommended and the 'symbols' font should be used for 
representing Greek characters.  
 
TeX/LaTeX: Authors submitting LaTeX files may use any of 
the standard class files such as article.cls, revtex.cls or 
amsart.cls. Non-standard fonts should be avoided; please 
use the default Computer Modern fonts. For the inclusion of 
graphics, we recommend graphicx.sty. Please use 
numerical references only for citations. There is no need to 
spend time visually formatting the manuscript: journal style 
will be imposed when the paper is prepared for publication. 
References should be included within the manuscript file 
itself.  
 
BibTeX bibliography files: Authors who wish to use 
BibTeX to prepare their references should therefore copy 
the reference list from the .bbl file that BibTeX generates 
and paste it into the main manuscript .tex file (and delete 
the associated \bibliography and \bibliographystyle 
commands). As a final precaution, authors should ensure 
that the complete .tex file compiles successfully on their own 
system with no errors or warnings, before submission. 
 
Title Page: The title page should bear the title of the paper, 
the full names of all the authors and their affiliations, 
together with the name, full postal address, telephone and 
e-mail address of the author to whom correspondence and 
offprint requests are to be sent (this information is also 
asked for on the electronic submission form).  
 
 The title should be brief, informative, of 170 characters 
or less.  
 The study design should be clearly stated in the 
title, in the form of a full explanatory clause 
separated from the main title by a colon. 
 The running title should consist of no more than 50 
letters and spaces. It should be as brief as possible, 
convey the essential message of the paper and 
contain no abbreviations.  
 Authors should disclose the sources of any support for 
the work, received in the form of grants and/or 
equipment and drugs. 
 If authors regard it as essential to indicate that two or 
more co-authors are equal in status, they may be 
identified by an asterisk symbol with the caption 
‘These authors contributed equally to this work’ 
immediately under the address list. 
 
Abstract: Abstracts should be unstructured and of no more 
than 250 words. 
 
Keywords: Preferably use up to six words chosen from 
MEDLINE MeSH, which best describe your paper. An 
accurate list of keywords will ensure correct indexing of your 
paper and increase its visibility in search engines. 
 
Introduction: The Introduction should assume that the 
reader is knowledgeable in the field and should therefore be 
as brief as possible, but can include a short background 
description/overview where desirable. 
 
Results: The Results section should briefly present the 
experimental data in text, tables or figures. Tables and 
figures should not be described extensively in the text. 
Section sub-headings can be used to aid clarity. 
 
Discussion: The discussion should focus on the 
interpretation and the significance of the findings with 
concise objective comments that describe their relationship 
to other work in the area. It should not repeat information in 
the results section. The following section headings should 
be used: 
 
 Main findings 
 Interpretation of findings in relation to previously 
published work 
 Strengths and limitations of this study 
 Implications for future research, policy and practice 
 Conclusions   
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Methods: This section should contain sufficient detail, so 
that all experimental procedures can be reproduced, and 
include references. However, methods that have been 
published in detail elsewhere should not be described in 
detail. Authors should provide the name and location of the 
manufacturer for any specifically named equipment and 
instruments; if applicable, all drugs should be identified by 
their pharmaceutical names, and by their trade name if 
relevant. Section sub-headings should be used to aid clarity. 
Availability of data and materials: An inherent principle of 
publication is that others should be able to replicate and 
build upon the authors' published claims. A condition of 
publication is that authors are required to make materials, 
data, code, and associated protocols promptly available to 
readers without undue qualifications.  
 
Submission of a manuscript to npj Primary Care Respiratory 
Medicine implies that materials described in the manuscript, 
including all relevant raw data, will be freely available to any 
scientist wishing to use them for non-commercial purposes, 
without breaching participant confidentiality.  
 
Data availability statements: Data availability statements 
provide a statement about where data supporting the results 
reported in a published article can be found - including, 
where applicable, hyperlinks to publicly archived datasets 
analysed or generated during the study. We encourage the 
provision of data availability statements, examples and 
details can be seen on our data policy web page. The 
statement should be placed at the end of the Methods 
section (titled, ‘Data availability’), after the code availability 
statement if one is present. For further guidance, please 
refer to the Data availability and data citations policy 
information and Frequently Asked Questions (FAQs). 
 
npj Primary Care Respiratory Medicine strongly encourages 
that all datasets on which the conclusions of the paper rely 
should be available to readers. We encourage authors to 
ensure that their datasets are either deposited in publicly 
available repositories (where available and appropriate) or 
presented in the main manuscript or additional supporting 
files whenever possible. Please see Springer Nature’s 
information on recommended repositories. General 
repositories - for all types of research data - such as 
figshare and Dryad may be used where appropriate.  
 
Where a widely established research community 
expectation for data archiving in public repositories exists, 
submission to a community-endorsed, public repository is 
mandatory. Persistent identifiers (such as DOIs and 
accession numbers) for relevant datasets must be provided 
in the paper. 
 
Acknowledgements: These should be brief and should 
include sources of support including sponsorship (e.g., 
university, charity, commercial organisation) and sources of 
material (e.g., novel drugs) not available commercially. 
 
Contributions: The exact role(s) of each author should be 
included in the declaration. For research manuscripts, one 
or more of the authors should be identified as the guarantor. 
Only those who have made substantial contributions to the 
study and/or preparation of the manuscript should be 
acknowledged as authors and named in full.  
 
Competing Interests: Authors must declare whether or not 
there are any competing interests in relation to the work 
described. This information must be included at this stage 
and will be published as part of the paper. Conflict of interest 
should be noted in the cover letter and in the paper. Please 
see the Conflict of Interest documentation in the Editorial 
Policy section for detailed information. 
 
Funding: Authors should declare the source of funding for 
their research, if applicable. 
References: All necessary references should be included in 
order to credit previous work directly relevant to the article. 
This should translate to a number of references within the 
range described in the article type specification section. 
References should follow the Vancouver format. In the text 
they should appear as superscript numbers starting at 1 and 
at the end of the paper they should be listed (double-
spaced) in numerical order corresponding to the order of 
citation in the text. Where a reference is to appear next to a 
number in the text, for example, following an equation, 
chemical formula or biological acronym, citations should be 
written as (ref. X) and not as superscript. Example: 
“detectable levels of endogenous Bcl-2 (ref. 3), as confirmed 
by western blot.” 
 
All authors should be listed for papers with up to six authors; 
for papers with more than six authors, the first six only 
should be listed, followed by et al. Abbreviations for titles of 
medical periodicals should conform to those used in the 
latest edition of Index Medicus. The first and last page 
numbers for each reference should be provided. Abstracts 
and letters must be identified as such. Papers in press may 
be included in the list of references. 
 
Personal communications must be allocated a number and 
included in the list of references in the usual way or simply 
referred to in the text; the authors may choose which 
method to use. In either case authors must obtain 
permission from the individual concerned to quote his/her 
unpublished work. 
 
Examples: 
Journal article, up to five authors: 
Belkaid, Y. & Rouse, B. T. Natural regulatory T cells in 
infectious disease. Nat. Immunol. 6, 353–360 (2005). 
 
Journal article, e-pub ahead of print: 
Bonin, M. et al. F-ara-A pharmacokinetics during reduced-
intensity conditioning therapy with fludarabine and 
busulfan. Bone Marrow Transplant. 
http://dx.doi.org/10.1038/sj.bmt.1705565 (2007). 
 
Journal article, in press: 
Gallardo, R. L., Juneja, H. S. & Gardner, F. H. Normal 
human marrow stromal cells induce clonal growth of human 
malignant T-lymphoblasts. Int. J. Cell Cloning (in the press). 
 
Complete book: 
Atkinson, K. et al. (eds) Clinical Bone Marrow and Blood 
Stem Cell Transplantation (Cambridge Univ. Press, 2004).  
 
Chapter in book: 
Harley, N. H. & Vivian, L. in Mechanisms of Disease 4th 
edn, Vol. 2 (eds Sodeman, W. A. & Smith, A.) Ch. 3 
(Saunders, 1974). 
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Abstract: 
Feig, S. A. et al. Bone marrow transplantation for 
neuroblastoma. Exp. Hematol. 13, abstr. 102 (1985). 
 
Preprint: 
Starrfelt, J. & Liow, L.H. How many dinosaur species were 
there? Fossil bias and true richness estimated using a 
Poisson sampling model (TRiPS). Preprint at 
http://biorxiv.org/content/early/2015/12/04/025940 (2015). 
Research dataset: 
Hao, Z., AghaKouchak, A., Nakhjiri, N. & Farahmand, A. 
Global Integrated Drought Monitoring and Prediction 
System (GIDMaPS) Data sets. figshare. 
http://dx.doi.org/10.6084/m9.figshare.853801 (2014). 
 
Figure Legends: These should be brief, specific and 
appear on a separate manuscript page after the References 
section.  
 
Tables: These should be labelled sequentially and cited 
within the text. Each table should be presented on its own 
page, numbered and titled. Reference to table footnotes 
should be made by means of Arabic numerals. Tables 
should not duplicate the content of the text. They should 
consist of at least two columns; columns should always 
have headings. Authors should ensure that the data in the 
tables are consistent with those cited in the relevant places 
in the text, totals add up correctly, and percentages have 
been calculated correctly. Tables should only be used to 
present essential data. Each must be on a separate sheet 
with a title or caption and be clearly labelled, sequentially. 
Please make sure each table is cited within the text and in 
the correct order, e.g. (Table 3). Tables should ideally be 
presented in Excel, one table per workbook. It is imperative 
that the tables are editable. Please save the files with 
extensions .xls / .xlsx / .ods / or .doc or .docx. Please 
ensure that you provide a 'flat' file, with single values in 
each cell with no macros or links to other workbooks or 
worksheets and no calculations or functions. 
 
Figures: Figures and images should be labelled 
sequentially and cited in the text. Figures should not be 
embedded within the text but rather uploaded as separate 
files. Detailed guidelines for submitting artwork can be found 
by downloading our Artwork Guidelines. The use of three-
dimensional histograms is strongly discouraged when the 
addition of the third dimension gives no extra information.  
 
2. PROTOCOLS 
 
For Protocols, the 1,500 words of text should be structured 
as follows: 
 Title and authors 
 Background  
 Aims 
 Methods (including details such as search strategy, 
study inclusion, setting, subjects, inclusion and 
exclusion criteria, outcome criteria, data extraction, 
methods of data analysis and synthesis, quality 
assessment, etc.) 
 Short discussion 
 Conflicts of Interest 
 Funding 
 References 
 Appendices (full details of search strategy, etc.) 
 
GENERAL INFORMATION 
 
Supplementary Information: Supplementary information 
(SI) is peer-reviewed material directly relevant to the 
conclusion of an article that is not included within the main 
body of the article. The article must be complete and self-
explanatory without the SI, which is posted on the journal's 
website and linked to the article. SI may consist of data files, 
graphics, movies or extensive tables. Please see our 
Artwork Guidelines for information on accepted file types.  
 
Authors should submit SI files in the FINAL format as they 
are not edited, typeset or changed, and will appear online 
exactly as submitted. When submitting SI, authors are 
required to:  
 Include a text summary (no more than 50 words) to 
describe the contents of each file. 
 Identify the types of files (file formats) submitted. 
 Include the text “Supplementary information is 
available at (journal name)’s website” at the end of the 
article and before the references. 
 
Reporting Tools: Please also ensure that, where relevant, 
the appropriate reporting guidance checklist (e.g. 
CONSORT for randomised controlled trials, PRISMA for 
systematic reviews, and STROBE for cohort, case-control 
and cross-sectional studies) has been completed and 
submitted as a supplementary file. These can be obtained 
from http://www.equator-network.org. 
 
In order to improve the overall transparency of reporting and 
the reproducibility of published results we require that you 
complete and submit the following reporting checklist 
http://www.nature.com/authors/policies/checklist_AJ.pdf. 
 
House Style 
 All pages and lines are to be numbered.  To add page 
numbers in MS Word, go to Insert then Page 
Numbers. To add line numbers go to File, Page Setup, 
then click the Layout tab. In the Apply to box, 
select Whole document, click Line Numbers then 
select the Add line numbering check box, followed by 
Continuous.  
 Use a coarse hatching pattern rather than shading for 
tints in graphs. 
 Colour should be distinct when being used as an 
identifying tool. 
 At first mention of a manufacturer, the town (and state 
if USA) and country should be provided.  
 Units: Use metric units (SI units) as fully as possible. 
Preferably give measurements of energy in kiloJoules 
or MegaJoules with kilocalories in parentheses (1 kcal 
= 4.186kJ). Use % throughout.  
 Abbreviations: On first using an abbreviation place it in 
parentheses after the full item. Very common 
abbreviations such as FFA, RNA, need not be defined. 
Note these abbreviations: gram g; litre l;  
 milligram mg; kilogram kg; kilojoule kJ; megajoule MJ; 
weight wt; seconds s; minutes min; hours h. Do not 
add s for plural units. 
 
Language Editing: npj Primary Care Respiratory Medicine 
is read by scientists from diverse backgrounds. In addition, 
many are not native English speakers. Authors should 
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therefore give careful thought to how their findings may be 
communicated clearly. Although a shared basic knowledge 
of biology may be assumed, please bear in mind that the 
language and concepts that are standard in one subfield 
may be unfamiliar to non-specialists. Thus, technical jargon 
should be avoided as far as possible and clearly explained 
where its use is unavoidable. Abbreviations, particularly 
those that are not standard, should also be kept to a 
minimum. The background, rationale and main conclusions 
of the study should be clearly explained. Titles and 
abstracts in particular should be written in language that will 
be readily intelligible to any scientist. 
 
Even though no paper will be rejected for poor language, 
non–native English speakers occasionally receive feedback 
from editors and reviewers regarding language and 
grammar usage in their manuscripts. You may wish to 
consider asking a colleague whose native language is 
English to read your manuscript and/or to use a professional 
editing service such as those provided by our affiliates 
Nature Research Editing Service or American Journal 
Experts. Please note that the use of a language editing 
service is not a requirement for publication in npj Primary 
Care Respiratory Medicine. 
 
Please note that the use of a language editing service is at 
the author's own expense and does not guarantee that the 
article will be selected for peer review or accepted. Authors 
connected with the IPCRG are welcome to approach the 
IPCRG for guidance. 
 
 
HOW TO SUBMIT 
 
Pre-submission Enquiries  
Please submit via our online manuscript submission system. 
 
Online Submission 
We only accept manuscript submission via our online 
manuscript submission system. Before submitting a 
manuscript, authors are encouraged to consult both our 
Editorial Policies and the submission instructions for our 
online manuscript submission system. If you have not 
already done so, please register for an account with our 
online manuscript system. You will be able to monitor the 
status of your manuscript online throughout the editorial 
process.  
 
Submission of Revisions 
Authors submitting a revised manuscript after review are 
asked to include the following: 
(1) A rebuttal letter, indicating point-by-point how you have 
addressed the comments raised by the reviewers. If you 
disagree with any of the points raised, please provide 
adequate justification in your letter.   
(2) A marked-up version of the manuscript that highlights 
changes made in response to the reviewers' comments 
in order to aid the Editors and reviewers. Do not use 
track changes or comments.  
(3) A 'clean' (non-highlighted) version of the revised 
manuscript. 
 
 
POST-ACCEPTANCE 
 
Once a manuscript is accepted, the corresponding author 
must complete and sign a Creative Commons licence and 
Article Processing Charge Payment form on behalf of all 
authors and return it to the editorial office. Failure to 
promptly return the form will result in delay of publication.  
 
Publication 
Publishing Open Access will mean the paper is freely 
accessible online immediately upon publication. By paying 
this charge authors are permitted to post the final, 
published PDF of their article on a website, institutional 
repository or other free public server, immediately on 
publication.   
 
Open access articles are published under a CC BY licence 
(Creative Commons Attribution 4.0 International Licence).  
The CC BY licence is preferred by many research funding 
bodies.  It allows for maximum dissemination and re-use of 
open access materials: users are free to share (copy, 
distribute and transmit) and remix (adapt) the contribution 
including for commercial purposes, providing they attribute 
the contribution in the manner specified by the author or 
licensor (read the full legal code). 
 
The CC BY-NC-ND and CC BY-NC-SA licences are 
available on request: please contact the editorial office on 
acceptance of your article to discuss these options. 
 
Under Creative Commons licences, authors retain 
copyright in their work. Authors should note that some 
funders require papers to be published under a specific 
licence and so should check the funder mandate to ensure 
compliance. 
 
With regards to payment, usual credit terms are 30 days 
from receipt of invoice. Failure to pay your invoice within 
the stated credit term may result in such penalties as 
restrictions on your ability to publish with Springer Nature in 
the future, involvement of a third party debt collection 
agency and legal proceedings. For further information on 
Open Access please see the FAQs page.  
 
Open Access Waiver 
Please note that some institutions have enacted Open 
Access policies that conflict with our own. If any 
corresponding or contributing authors are from these 
institutions, you will need to provide a waiver from the 
institution of every affected author, which can be obtained 
from the institution. This waiver should be submitted at the 
same time as the Open Access Licence to Publish form.  
 
Proofs  
The corresponding author will receive an e-mail containing 
a URL linking to the proofing site. Proof corrections must 
be returned within 48 hours of receipt. Failure to do so may 
result in delayed publication. Extensive corrections cannot 
be made at this stage.  
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Final Publication  
The final version of the manuscript is published online and 
represents the official version of the manuscript. 
 
Self-Archiving 
Authors are encouraged to submit the final version of the 
accepted, peer-reviewed manuscript to their funding body's 
archive for public release immediately upon publication 
and to deposit the final version on their institution’s 
repository. Authors should cite the publication reference 
and DOI number on any deposited version, and provide a 
link from it to the published article on the Nature Research 
website. 
 
This policy complements the policies of the US National 
Institutes of Health, the Wellcome Trust and other research 
funding bodies around the world. Springer Nature 
recognises the efforts of funding bodies to increase access 
of the research they fund, and strongly encourages authors 
to participate in such efforts. 
 
 
PUBLICATION CHARGES 
 
Article Processing Charge 
Authors whose papers are accepted for publication in npj 
Primary Care Respiratory Medicine are required to pay an 
Article Processing Charge (APC).    
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